PuSH - Publikationsserver des Helmholtz Zentrums München

Eriksen, R.* ; White, M.C.* ; Dawed, A.Y.* ; Garcia Perez, I.* ; Posma, J.M.* ; Haid, M. ; Sharma, S. ; Prehn, C. ; Thomas, L.E.* ; Koivula, R.W.* ; Bizzotto, R.* ; Mari, A.* ; Giordano, G.N.* ; Pavo, I.* ; Schwenk, J.M.* ; De Masi, F.* ; Tsirigos, K.D.* ; Brunak, S.* ; Viñuela, A.* ; Mahajan, A.* ; McDonald, T.J.* ; Kokkola, T.* ; Rutters, F.* ; Beulens, J.* ; Muilwijk, M.* ; Blom, M.T.* ; Elders, P.* ; Hansen, T.H.* ; Fernandez-Tajes, J.* ; Jones, A.* ; Jennison, C.* ; Walker, M.* ; McCarthy, M.I.* ; Pedersen, O.* ; Ruetten, H.* ; Forgie, I.* ; Holst, J.J.* ; Thomsen, H.S.* ; Ridderstråle, M.* ; Bell, J.D.* ; Adamski, J. ; Franks, P.W.* ; Hansen, T.* ; Holmes, E.* ; Frost, G.* ; Pearson, E.R.*

The association of cardiometabolic, diet and lifestyle parameters with plasma glucagon-like peptide-1: An IMI DIRECT study.

J. Clin. Endocrinol. Metab. 109, e1697-e1707 (2024)
Verlagsversion DOI PMC
Open Access Hybrid
Creative Commons Lizenzvertrag
CONTEXT: The role of glucagon-like peptide-1(GLP-1) in Type 2 diabetes (T2D) and obesity is not fully understood. OBJECTIVE: We investigate the association of cardiometabolic, diet and lifestyle parameters on fasting and postprandial GLP-1 in people at risk of, or living with, T2D. METHOD: We analysed cross-sectional data from the two Innovative Medicines Initiative (IMI) Diabetes Research on Patient Stratification (DIRECT) cohorts, cohort 1(n=2127) individuals at risk of diabetes; cohort 2 (n=789) individuals with new-onset of T2D. RESULTS: Our multiple regression analysis reveals that fasting total GLP-1 is associated with an insulin resistant phenotype and observe a strong independent relationship with male sex, increased adiposity and liver fat particularly in the prediabetes population. In contrast, we showed that incremental GLP-1 decreases with worsening glycaemia, higher adiposity, liver fat, male sex and reduced insulin sensitivity in the prediabetes cohort. Higher fasting total GLP-1 was associated with a low intake of wholegrain, fruit and vegetables inpeople with prediabetes, and with a high intake of red meat and alcohol in people with diabetes. CONCLUSION: These studies provide novel insights into the association between fasting and incremental GLP-1, metabolic traits of diabetes and obesity, and dietary intake and raise intriguing questions regarding the relevance of fasting GLP-1 in the pathophysiology T2D.
Impact Factor
Scopus SNIP
Altmetric
5.000
0.000
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter GLP-1; type 2 diabetes; prediabetes; liver fat; obesity; insulin resistance; incretin; nutrition; diet; cardiometabolic markers; Mixed Meal; Glp-1; Secretion; Discovery; Cells; Risk
Sprache englisch
Veröffentlichungsjahr 2024
HGF-Berichtsjahr 2024
ISSN (print) / ISBN 0021-972X
e-ISSN 1945-7197
Quellenangaben Band: 109, Heft: 9, Seiten: e1697-e1707 Artikelnummer: , Supplement: ,
Verlag Endocrine Society
Verlagsort Bethesda, Md.
Begutachtungsstatus Peer reviewed
Institut(e) Molekulare Endokrinologie und Metabolismus (MEM)
Institute of Epidemiology (EPI)
POF Topic(s) 30201 - Metabolic Health
30202 - Environmental Health
Forschungsfeld(er) Genetics and Epidemiology
PSP-Element(e) G-505600-003
G-504091-002
Förderungen
Wellcome
Rutherford Fund Fellowship at Health Data Research (HDR) UK
NIHR Fellowship
Imperial College National Institute for Health Research (NIHR) BRC
European Union
Novo Nordisk Foundation
Swedish Research Council, Linnaeus
Swedish Foundation for Strategic Research
Lund University Diabetes Centre
Swedish Research Council
STAR Award Novo Nordisk
NIHR (Niddk)
Innovative Medicines Initiative Joint Undertaking
Scopus ID 85201230805
PubMed ID 38686701
Erfassungsdatum 2024-05-21